Fernanda Visit 1: A 53-year-old Hispanic woman with cardiometabolic risk factors

Title:

Fernanda Visit 1: A 53-year-old Hispanic woman with cardiometabolic risk factors

Topic: Endocrinology
Relevant Terms: Diabetes, Micro And Macrovascular Complications, Nephropathy, Quality Measures, T2DM
Primary Audience: Primary Care Physicians
Launch Date: 18-Dec-13
Credits: 0.75 AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Type 2 Diabetes and Renal Function: An Overview of Diagnosis, Management, and Cardiovascular...

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Accurately diagnose and stage renal dysfunction, particularly in the elderly and specific ethnic groups, in T2DM patients for optimal individualized treatment decisions
  2. Appropriately utilize incretin agents as part of the armamentarium for individualized T2DM management, facilitating early attainment and ongoing maintenance of A1C targets, while reducing hypoglycemia and improving cardiovascular risk factor profile
  3. Incorporate patient education tools into practice to promote a shared decision-making approach and enhance patient participation in the T2DM management decision process
  4. Initiate appropriate screening for cardiovascular risk in T2DM based on the relationship between CVD and renal dysfunction

    Faculty

    Ellen Miller, MD
    Associate Professor of Medicine
    Hofstra North Shore-LIJ School of Medicine
    Uniondale, NY
    Louis Kuritzky, MD
    Clinical Assistant Professor
    Department of Community Health and Family Medicine
    University of Florida
    Gainesville, FL
    Mathew R. Weir, MD
    Professor and Director
    Division of Nephrology
    University of Maryland School of Medicine
    Baltimore, MD
    DISCLOSURE POLICY STATEMENT
    Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
     
    All persons in a position to control the content of a continuing medical education program sponsored by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.
     
    The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.
     
    Faculty Disclosures
    The faculty reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
     
    Louis Kuritzky, MD: Consultant: Boehringer Ingelheim, Forest, Janssen, Lilly, Novo Nordisk, Sanofi, Takeda
     
    Ellen Hirschman Miller, MD: Speaker: Boehringer Ingelheim
     
    Matthew R. Weir, MD: Scientific Advisor: Amgen, Janssen, Otsuka, Sanofi; Executive Committee: Relypsa
     
    Non-faculty Content Contributors:
    Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

    Carole Drexel, PhD, CCMEP; Blair St. Amand; Jay Katz, CCMEP; CME Peer Review: Nothing to disclose

    DISCLOSURE ATTESTATION
     
    DISCLAIMER
    The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
     
    CREDIT DESIGNATION
    The Potomac Center for Medical Education designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians  should only claim credit commensurate with the extent of their participation in the activity.
     
    For questions regarding CME credit, the post-test, or evaluation, please email contact@rockpointe-pcme.com.
     
    ACCREDITATION STATEMENT
    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    HOW TO RECEIVE CREDIT
    By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 0.75 AMA PRA category 1 credits™. Statement of credit will be available to print from your user history page.
     
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the post-test and activity evaluation.
    • Physicians who successfully complete the post-test and evaluation will receive CME credit. You must score with a 70% or higher on the post-test to receive credit for this activity.
    • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
       
    COMMERCIAL SUPPORT
    This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc., which is made possible, in part, through collaboration with Eli Lilly and Company.
     
    This continuing medical education activity is jointly sponsored by the Potomac Center for Medical Education and Rockpointe.